versión imprimible

6th Annual RAS-Targeted Drug Development Summit

Evvnt Promotion / evvnt
24.09.2024 - 26.09.2024  Hilton Boston Park Plaza, 50 Park Plaza, 02116 Boston, Massachusetts, USA
Time: 8:00 AM - 4:45 PM
Temas de la conferencia
Uniting Large Pharma, Innovative Biotech and Leading Academics to Defeat the Holy Grail Target in Precision Oncology

With tumor and patient heterogeneity, the quest to target the remaining RAS mutants continues, and now more than ever, we are witnessing this industry make great strides in utilizing novel modalities and elucidating mechanisms of resistance.
Organizador profesional (PCO)
Hanson Wade Group

Speakers: Ahmadur Rahman, Senior Clinical Director and Clinical Science Lead, Global Oncology Research and Development, Roche, and more

Información e inscripción:
Medicina General
Cuota del Congreso
USD 2599.00 - USD 5097.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

newTreeOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Helix - Forschung & Beratung WienEuropean Health Forum GasteinÖsterreichische Akademie der ÄrzteÄrzte der WeltEuropean Public Health Association (EUPHA)Anästhesie in Entwicklungsländern e. V.